Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
- Evidence-Based Medicine
- Health Care Quality, Access, and Evaluation
- Inappropriate Prescribing
- Primary Health Care
Public payment for medicines is key to equity of access, as are reimbursement decisions aligned with genuine therapeutic advantage. To optimise benefits and minimise harm, support for rational medicine use (called ‘quality use of medicines’ in Australia) is also needed. Australia’s independent National Prescribing Service (‘NPS MedicineWise’ or NPS) was set up in 1998 to support quality use of medicines as a key component of Australia’s National Medicines Policy. After nearly 25 years of delivering high-quality services to improve the use of medicines, NPS’ board announced in September that it will close at the end of 2022 due to loss of government funding.
Why this happened remains unclear. The first inkling was a review by Professor Lloyd Sansom commissioned by the Australian Department of Health.1 The largely supportive report highlighted: ‘almost universal acknowledgement that NPS MedicineWise produces high quality resources’ and ‘a general consensus of support for the work of the organisation’. The report identified some areas …
Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).
Provenance and peer review Commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.